French Society for Biological Psychiatry and Neuropsychopharmacology and French-speaking Marce Society guidelines for the management of mood disorders in women before, during, and after pregnancy - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Archives of Women's Mental Health Année : 2024

French Society for Biological Psychiatry and Neuropsychopharmacology and French-speaking Marce Society guidelines for the management of mood disorders in women before, during, and after pregnancy

Raoul Belzeaux
  • Fonction : Auteur
Florence Gressier
  • Fonction : Auteur
Ludivine Boudieu
  • Fonction : Auteur
Adeline Arnould
  • Fonction : Auteur
Elsa Moreau
  • Fonction : Auteur
Julia Pastol
  • Fonction : Auteur
Eleni Tzavara
  • Fonction : Auteur
Ludovic Samalin
  • Fonction : Auteur

Résumé

PURPOSE: The French Society for Biological Psychiatry and Neuropsychopharmacology and the French-speaking Marcé Society have joined forces to establish expert recommendations on the prescription of psychotropic drugs before, during, and after pregnancy in women with major depressive disorder (MDD) and bipolar disorder (BD). METHODS: To elaborate recommendations, we used the RAND/UCLA Appropriateness Method, which combines scientific evidence and expert clinicians' opinions. A written survey was completed by 48 psychiatrists, who have expertise in the management of mood disorders and/or in perinatal psychiatry. Key recommendations are provided by the scientific committee based on data analysis and interpretation of the results of the survey. RESULTS: The recommendations address the following three areas that are deemed essential in women with mood disorders, with an emphasis on screening, treatment options, and monitoring: (i) management of mood disorders in women of childbearing age, (ii) management during pregnancy, (iii) management during the post-partum period. As first-line strategies, experts recommend treating mood symptoms during pregnancy and maintaining a pharmacological treatment, even in euthymic or stabilized patients. First-line options include only medications with no teratogenic risk, and during breastfeeding, only medications without evidence of adverse effects in nursing infants. CONCLUSION: The expert consensus guidelines will help facilitate treatment decisions for clinicians in the daily assessment and management of mood disorders in women of childbearing age, during pregnancy, and in the post-partum period.
Fichier non déposé

Dates et versions

hal-04502527 , version 1 (13-03-2024)

Identifiants

Citer

Raoul Belzeaux, Florence Gressier, Ludivine Boudieu, Adeline Arnould, Elsa Moreau, et al.. French Society for Biological Psychiatry and Neuropsychopharmacology and French-speaking Marce Society guidelines for the management of mood disorders in women before, during, and after pregnancy. Archives of Women's Mental Health, 2024, ⟨10.1007/s00737-024-01440-6⟩. ⟨hal-04502527⟩

Collections

U1219
0 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More